EUVIMEDEUVIMED entdecken
Crossref

Etomidate relieves oxaliplatin-induced neuropathic pain by regulating AMPK/Nrf2/HO-1 axis

Kexin Chen, Yuchao Lin, Xuechang Han, Lei Zhao, Jing Wang, Yu Li

Molecular and Cellular Endocrinology · 2026-04 · 112791

DOI: 10.1016/j.mce.2026.112791 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2026-04. Verfasst von Kexin Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain, The First Affiliated Hospital of Henan University of science and Technology, Luoyang, Henan, 471003, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Etomidate (Eto) is widely employed in clinical anesthesia induction. Whereas, the function of Eto in neuropathic pain caused by anticancer chemotherapeutic drug remains indistinct. Hereof, the research attempted to unveil the regulatory mechanisms of Eto in oxaliplatin (OXA) elicited neuropathic pain. MATERIAL AND METHODS The mice model was established by OXA induction and administrated by Eto along with the concentrations of 1.5, 3 and 6 mg/kg. The nociceptive behaviors such as paw withdrawal threshold (PWT), flinches, paw withdrawal latency (PWL) and latency were analyzed. By executing HE staining, RT-qPCR, western blot and the corresponding kits, the influences of Eto in inflammatory response and oxidative stress response in OXA model were explored. AMPK/Nrf2/HO-1 pathways were studied to uncover the potential mechanism. After creation of C6 cells model, the effects of Eto in neuropathic pain were further investigated in vitro. RESULTS Eto significantly relieved OXA-irritated nociceptive behaviors via elevating the values of PWT and PWL, declining the number of spontaneous flinches, meanwhile restoring latency to fall. Moreover, Eto triggered a robust anti-inflammatory response, which lowered inflammatory scores and suppressed GFAP, IL-1β, TNF-α and NLRP3 expression. Additionally, Eto obviously enhanced SOD and GSH levels, but reduced MDA and COX2 levels, thereby mitigating OXA-induced oxidative stress response. Mechanism study discovered that activation of AMPK/Nrf2/HO-1 pathways participated in regulating the neuroprotective function of Eto in inflammatory response and oxidative stress response in OXA-treated mice and in C6 cells model. CONCLUSIONS The research announced that Eto improved OXA-induced neuropathic pain by regulating AMPK/Nrf2/HO-1 pathway.

Schlagwörter

Stichwörter der Autor:innen

AMPK/Nrf2/HO-1 pathwayetomidateinflammatory responseoxaliplatinoxidative stress response

Autor:innen und Institutionen

  • Department of Anesthesiology and Pain, The First Affiliated Hospital of Henan University of science and Technology, Luoyang, Henan, 471003, China.
  • Department of Anesthesiology, The First Affiliated Hospital of Henan University of science and Technology, Luoyang, Henan, 471003, China.
  • Department of Anesthesiology and Pain, The First Affiliated Hospital of Henan University of science and Technology, Luoyang, Henan, 471003, China. Electronic address: ttkyuli64255@sina.com.

Zitieren

APA

Chen, K., Lin, Y., Han, X., Zhao, L., Wang, J., & Li, Y. (2026). Etomidate relieves oxaliplatin-induced neuropathic pain by regulating AMPK/Nrf2/HO-1 axis. Molecular and Cellular Endocrinology, 112791. https://doi.org/10.1016/j.mce.2026.112791

Vancouver

Chen K, Lin Y, Han X, Zhao L, Wang J, Li Y. Etomidate relieves oxaliplatin-induced neuropathic pain by regulating AMPK/Nrf2/HO-1 axis. Molecular and Cellular Endocrinology. 2026:112791. doi:10.1016/j.mce.2026.112791

BibTeX
@article{Chen2026,
  author = {Chen, Kexin and Lin, Yuchao and Han, Xuechang and Zhao, Lei and Wang, Jing and Li, Yu},
  title = {Etomidate relieves oxaliplatin-induced neuropathic pain by regulating AMPK/Nrf2/HO-1 axis},
  journal = {Molecular and Cellular Endocrinology},
  year = {2026},
  pages = {112791},
  doi = {10.1016/j.mce.2026.112791}
}
Kostenlos starten →